Delivery Order SPE2DR25D3012-SPE2DR26F4E0R
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zilretta 32 mg vials with a ceiling value of $9,287.25. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Zilretta is a intra-articular corticosteroid injection used for osteoarthritis pain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zilretta 32 mg vials, a corticosteroid injection used for osteoarthritis pain management. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,438.60 and is scheduled for completion by December 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,714.90 on September 25, 2025, for the supply of Zilretta 32 mg vials, with performance completion targeted for October 17, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a ceiling value of $1,078.95 under firm fixed-price terms. The award was made on December 17, 2025, with an ultimate completion date of January 9, 2026. This competitive delivery order, issued without a set-aside designation, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Zilretta is a triamcinolone acetonide...
- The Defense Logistics Agency awarded a $3,714.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 7, 2025. This non-set-aside contract, awarded on September 16, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. Zilretta is a corticosteroid injection used for osteoarthritis pain management, and this order fulfills medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Zilretta 32 mg vials, a corticosteroid injection used for joint pain management. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $8,631.84 and is scheduled for completion by January 7, 2026. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,157.96 firm fixed price delivery order for Zilretta 32 mg vials on November 3, 2025, with an ultimate completion date of November 25, 2025. This award is a non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The delivery order will be...
- The Defense Logistics Agency awarded a $17,831.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 17, 2025. This non-set-aside contract was competitively awarded on September 25, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, representing a specialized...
- The Defense Logistics Agency awarded a $7,429.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 7, 2025. This non-set-aside competitive award was issued on September 16, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 1, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4E0RDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Zilretta 32 mg vials, with a ceiling value of $5,754.56 and a firm fixed price structure. The contract is non-competitive and categorized as a child delivery order, with an ultimate completion date of January 15, 2026. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Zilretta is a corticosteroid injection used for intra-articular administration in the treatment of osteoarthritis pain, representing a specialized pharmaceutical supply for military or defense healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The non-set-aside status and competitive history of the prime IDC demonstrate the contractor's demonstrated capability to meet federal procurement standards through open competition, positioning it as a key supplier for military and defense health system pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 12/22/25 |